Towards a self-adjuvanting multivalent B and T cell epitope containing synthetic glycolipopeptide cancer vaccine.
Renaudet
Olivier
O
Département de Chimie Moléculaire, UMR-CNRS 5250 & ICMG FR 2607, Université Joseph Fourier, 38041 Grenoble Cedex 9, France.
BenMohamed
Lbachir
L
Dasgupta
Gargi
G
Bettahi
Ilham
I
Dumy
Pascal
P
D000818:Animals; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology*; D045744:Cell Line, Tumor; D018985:Epitopes, B-Lymphocyte; D018984:Epitopes, T-Lymphocyte; D006020:Glycopeptides / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D014614:Vaccines, Synthetic / Q000276:immunology*
D015295:Antigens, Tumor-Associated, Carbohydrate; D019496:Cancer Vaccines; D018985:Epitopes, B-Lymphocyte; D018984:Epitopes, T-Lymphocyte; D006020:Glycopeptides; D014614:Vaccines, Synthetic